Related by context. All words. (Click for frequent words.) 70 ALK inhibitor 66 investigational humanized monoclonal antibody 66 orally administered inhibitor 66 histone deacetylase inhibitor 65 selective immunoproteasome inhibitor 65 FOLOTYN ® 65 IgG1 monoclonal antibody 65 PNP inhibitor 65 investigational pan BCR 64 peripherally acting 64 targeted antifolate 64 Personalized Immunotherapy 64 multi kinase inhibitor 63 IAP inhibitor 63 oral prodrug 63 selective modulator 63 selective inhibition 63 Vidaza azacitidine 63 Panzem R 63 IL# PE#QQR 63 liposomal formulation 63 Familial Adenomatous Polyposis FAP 63 targeting CD# 63 selective kinase inhibitor 63 virus HCV protease inhibitor 63 anticancer compound 63 PDX pralatrexate 63 candidate deforolimus 63 hypoxia activated prodrug 62 Preclinical studies suggest 62 small molecule tyrosine 62 MKC# MT 62 Romidepsin 62 AAG geldanamycin analog 62 Pivotal Phase III 62 RNAi therapeutic targeting 62 Liposomal 62 candidate AP# 62 phase III isavuconazole 62 histone deacetylase HDAC inhibitor 62 novel peptide 62 Safinamide 62 investigational antiplatelet agent 62 novel histone deacetylase 62 CEQ# 62 proteasome inhibitor 62 ABL inhibitor 61 Tezampanel 61 PKC# 61 lexidronam injection 61 huC# DM4 61 TLK# 61 Aviptadil 61 candidate AQ4N 61 MEK inhibitor 61 Methylnaltrexone 61 Squalamine 61 Cloretazine R 61 LEP ETU 61 Anidulafungin 60 Civacir 60 Luteinizing Hormone Releasing Hormone 60 intranasal formulation 60 targeted radiotherapeutic 60 polymerase inhibitor 60 Cintredekin Besudotox 60 receptor tyrosine kinase inhibitor 60 mitogen activated ERK kinase 60 MAGE A3 ASCI 60 tiapamil 60 non alcoholic steatohepatitis 60 IMiDs R 60 nucleoside analog 60 PrevOnco 60 dasatinib Sprycel ® 60 Soliris eculizumab 60 antisense drug 60 orally bioavailable 60 AEG# 60 ADP receptor antagonist 60 Friedreich Ataxia FRDA 60 Onalta ™ 60 humanized anti 59 fosbretabulin 59 PSN# [002] 59 TÎ ² 4 59 DOS# 59 mertansine 59 acadesine 59 IAP inhibitors 59 prostaglandin synthesis 59 Vandetanib 59 Soliris TM eculizumab 59 sorafenib Nexavar 59 depsipeptide 59 Pazopanib 59 cutaneous T 59 angiogenesis inhibitor 59 Eculizumab 59 hoFH 59 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 59 topically applied SEPA 59 Onconase 59 generation purine nucleoside 59 rHuPH# recombinant human 59 histone deacetylase HDAC inhibitors 59 novel VDA molecule 59 investigational hepatitis C 59 vapreotide acetate 59 signal transduction inhibitor 59 Ecallantide 59 TAFA# 59 Tesetaxel 59 HDACi 59 somatostatin analogue 59 PEGylated anti 59 lucinactant 59 Factor VIIa 59 Elvitegravir 59 hyaluronidase enzyme 59 Phase Ib clinical trials 58 Pancreas Cancer Vaccine 58 Afatinib 58 docetaxel Taxotere ® 58 Nanobody 58 GRNVAC1 58 Aflibercept 58 Zybrestat 58 injectable formulation 58 PI3K/Akt pathway inhibitor 58 Carfilzomib 58 Liprotamase 58 Small Molecule 58 hedgehog pathway 58 PEG SN# 58 tafamidis 58 MKC# MKC# PP 58 Replacement Therapy 58 R roscovitine 58 antibody MAb 58 inhaled formulation 58 humanized monoclonal antibody 58 dexpramipexole 58 oral dual endothelin 58 PI3K/mTOR 58 aripiprazole Abilify 58 JAK2 inhibitor 58 radiation sensitizer 58 Dalbavancin 58 Myolimus 58 orally dosed 58 Cannabinor 58 erlotinib Tarceva ® 58 Phase III Clinical Trial 58 HCV protease inhibitor 58 Clofarabine 58 non nucleoside HCV 58 oral Janus kinase 57 BENLYSTA ® 57 IMiD 57 etanercept Enbrel 57 opioid receptor antagonist 57 investigational monoclonal antibody 57 dasatinib Sprycel 57 Nexavar sorafenib 57 Iluvien ® 57 diarrhea predominant irritable 57 reslizumab 57 PEGylated Fab fragment 57 autologous cellular immunotherapy 57 ATPace TM 57 treat chronic sinusitis 57 c myb 57 subcutaneous formulation 57 anticancer agent 57 tyrosine kinase inhibitor 57 immunotherapeutic vaccine 57 inhibit angiogenesis 57 multicenter Phase II 57 Gleevec resistant 57 Bioral ® 57 Cloretazine ® 57 TELINTRA 57 PDE4 inhibitor 57 P#X# 57 Gamma secretase 57 mTOR inhibitor 57 Pralatrexate 57 immunomodulatory therapy 57 LHRH antagonist 57 Omacetaxine 57 Cetrorelix 57 Maribavir 57 MEK inhibitors 57 Sym# 57 Elagolix 57 seliciclib CYC# 57 p# inhibitor 57 SERMs 57 investigational oral 57 IMA# 57 PORxin TM 57 Cloretazine 57 prokinetic agent 57 immune modulation 57 vascular disrupting agent 57 LymphoStat B TM 57 CINTREDEKIN BESUDOTOX 57 CCX# 57 histamine dihydrochloride 56 OXi# 56 radiotherapeutic 56 selective A2A adenosine receptor 56 GTC recombinant human 56 Inhalation Solution 56 Panzem R NCD 56 Qutenza TM 56 dermal patch 56 methylnaltrexone bromide 56 SinuNase TM 56 Romiplostim 56 AT1R 56 small molecule chemotherapeutic 56 adalimumab Humira 56 JAK inhibitor 56 peptibody 56 Bucindolol 56 VitiGam 56 ketolide antibiotic 56 OvaRex R 56 Amrubicin 56 Vascugel 56 SNT MC# 56 metaglidasen 56 laropiprant 56 Hsp# Inhibitor 56 SCH # 56 ALN TTR# 56 EZN 56 Genasense ® oblimersen 56 Pivotal Trial 56 vinca alkaloid 56 Transcriptional 56 Neulasta ® 56 hormone LHRH antagonist 56 rheumatoid arthritis psoriatic arthritis 56 Arimoclomol 56 CCR5 antagonist 56 CYT# 56 investigational 56 Tyrima 56 Phase #b/#a clinical 56 SUTENT ® 56 HepaGam B 56 kinase pathway 56 MGCD# [001] 56 AP# [003] 56 DPP4 inhibitor 56 cysteamine bitartrate 56 treat nicotine addiction 56 cyclooxygenase 2 56 6R BH4 56 VNP#M 56 Junovan TM 56 Cleviprex TM clevidipine 56 Aliskiren 56 FACTIVE R gemifloxacin 56 steroidogenesis 56 mapatumumab 56 humanised antibody 56 pregabalin Lyrica 56 DURIN TM 56 phase IIb clinical 56 Pradefovir 56 sorafenib tablets 56 investigational compounds 55 personalized dendritic cell 55 novel immunomodulatory 55 CA4P 55 Bone Graft 55 rNAPc2 55 ProLindac TM 55 PLK1 SNALP 55 SARMs 55 AQ4N 55 Microplasmin 55 Dapagliflozin 55 Azedra 55 Tarceva TM 55 Avastin bevacizumab 55 volociximab 55 Estrogen Receptor 55 relapsed leukemia 55 acetylcholinesterase AChE 55 prostanoid 55 PrevOnco ™ 55 Proteasome 55 immunomodulator 55 LPM TM 55 Irinotecan 55 investigational pharmacologically unique 55 sodium stibogluconate 55 Elesclomol 55 Radezolid 55 gastrointestinal stromal tumors GIST 55 liver resection surgeries 55 Yondelis ® 55 beta adrenergic 55 ospemifene 55 Cytotoxic T 55 Kahalalide F 55 HDAC inhibitor 55 XL# anticancer compounds 55 Proxinium TM 55 Archexin 55 MNTX 55 Trofex 55 Alinia 55 TBC# 55 Daclizumab 55 alvespimycin 55 Known generically 55 EP #R 55 Vicinium TM 55 intravenously administered 55 oral immunomodulatory 55 castrate resistant prostate cancer 55 OHR/AVR# 55 EFAPROXYN 55 Phase IIb clinical trials 55 HGS# 55 ATL# [002] 55 OncoVex 55 ILUVIEN ® 55 Tarvacin TM 55 Plasmin 55 Ceflatonin 55 Afinitor everolimus 55 Raptiva R 54 EVIZON TM 54 mTOR signaling 54 immunological diseases 54 levetiracetam Keppra 54 Protein Kinase 54 valent conjugate vaccine 54 DB# [003] 54 BN# [002] 54 OvaRex ® MAb 54 NeuroSTAT ® 54 RANK Ligand inhibitor 54 #D#C# 54 CTLA4 Ig 54 BrachySil 54 oral anticancer 54 Factor Xa inhibitor 54 vorinostat 54 TG# [003] 54 vidofludimus 54 antifibrotic 54 Everolimus 54 ongoing Phase 1b 54 PDGF receptor 54 PPAR gamma agonist 54 Tocilizumab 54 Rebif ® 54 intravenous IV formulation 54 Sanvar R 54 Onco TCS 54 YONDELIS 54 nasal calcitonin product 54 Mipomersen 54 nucleotide analogue 54 Nimotuzumab 54 ixabepilone 54 neratinib 54 BiTE 54 NV1FGF 54 trastuzumab DM1 T DM1 54 Ofatumumab 54 HCV protease inhibitors 54 PROVENGE sipuleucel T 54 RhuDex ® 54 Ambrisentan 54 Levoleucovorin 54 Neuroprotection 54 bortezomib Velcade 54 LE SN# 54 ATL# [001] 54 Clevudine 54 OLpur TM MD 54 Golimumab 54 Neuvenge 54 lorvotuzumab mertansine 54 CB2 selective receptor agonist 54 forodesine 54 antifungal agent 54 Kamada AAT 54 Hematopoietic 54 cannabinor 54 Proellex TM 54 AA amyloidosis 54 Tanespimycin 54 EOquin 54 Zolinza 54 herpetic keratitis 54 Aryplase 54 mild vasodilator 53 oral antiviral 53 fluoroquinolone antibiotic 53 pertuzumab 53 pancreatic enzyme replacement 53 octreotide acetate 53 Enhanze Technology 53 Zenvia Phase III 53 Aplidin 53 KRN# 53 Pimavanserin 53 investigational immunotherapy 53 Perifosine 53 Glucocorticoid 53 Nexavar ® 53 rasagiline tablets 53 candidate REP# 53 DermaVir Patch 53 Triolex 53 serine protease inhibitor 53 BCR ABL inhibitor 53 Sipuleucel T 53 topiramate Topamax 53 vemurafenib 53 investigational therapies 53 BrachySil TM 53 orally administered 53 LibiGel ® 53 Blinatumomab 53 preclinical efficacy 53 HepaSphere 53 thymalfasin 53 ALGRX 53 Ganciclovir 53 Eluting Coronary Stent System 53 Laquinimod 53 Altropane 53 OMNARIS HFA 53 Noxafil 53 Traficet EN 53 superficial bladder cancer 53 Allovectin 7 53 Mycamine 53 INCB# [001] 53 BCR ABL inhibitors 53 BiTE antibody 53 thrombin inhibitor 53 UPLYSO 53 thyroid hormone receptor 53 Erbitux cetuximab 53 IMP# 53 Molecular Cancer 53 ATD TM gel 53 immunotherapeutic agent 53 Fx #A 53 Aurexis 53 perifosine KRX 53 TAXUS Element Paclitaxel Eluting 53 Bremelanotide 53 SYCREST 53 Stromal 53 ELACYT 52 Orphan Drug designations 52 faropenem medoxomil 52 INC# 52 BAY #-# 52 Rasagiline 52 diabetic neuropathic pain 52 renin inhibitors 52 pharmacokinetic PK study 52 cilengitide 52 C1 inhibitor rhC1INH 52 FAAH 52 Icatibant 52 Ticagrelor 52 levocetirizine 52 Phase IIa trial 52 anticancer therapies 52 echinocandin 52 ZOLINZA 52 Conjugated 52 subcutaneously administered 52 Loxapine 52 Lixivaptan 52 Dupuytren Contracture 52 Zenpep 52 investigational hepatitis B 52 signaling cascades 52 Fingolimod 52 Teriflunomide 52 RhuDex 52 immunotherapeutic 52 Drug Eluting Stent System 52 Besivance 52 Tolvaptan 52 Silodosin 52 Emezine 52 Eltrombopag 52 Iluvien TM 52 Lacosamide 52 ganetespib 52 direct renin inhibitor 52 monocytes macrophages 52 Interferon alpha 52 LEUKINE 52 RNA Interference 52 Corlux 52 M Vax 52 cediranib 52 Etravirine 52 Ciclesonide 52 protein phosphorylation 52 HepG2 52 Phase #b/#a trial 52 L BLP# 52 cancer immunotherapy 52 novel oral anticoagulant 52 Velcade bortezomib 52 thrombolytic agent 52 ruxolitinib 52 cintredekin besudotox 52 Telavancin 52 oral transmucosal 52 antitumoral 52 visilizumab 52 NXL# 52 Troxatyl 52 DU #b 52 HQK 52 metastatic hormone refractory 52 Sutent sunitinib 52 GLP toxicology studies 52 Tofacitinib 52 Orphan Drug 52 oncogenic signaling 52 Phenoptin 52 Zingo TM 52 oral anticoagulant 52 Avanafil 52 Medidur TM FA 52 Vernakalant 52 investigational compound 52 MOZOBIL 52 Oxytrex TM 52 PD LID 52 pralatrexate 52 TREANDA 52 Smoothened 52 Remicade infliximab 51 subcutaneous SC 51 Talabostat 51 acyclovir Lauriad R 51 investigational drug 51 MAP# 51 antiplatelet agent 51 Chemophase 51 Galectin 3 51 Crizotinib 51 torezolid phosphate 51 EGFR pathway 51 methylnaltrexone 51 sunitinib malate 51 Amphotericin B 51 axitinib 51 nucleoside analogue 51 intravenous acetaminophen 51 ASONEP 51 Prodarsan ® 51 HIV integrase inhibitor 51 cAMP signaling 51 Wnt beta catenin 51 Low Dose 51 Linjeta TM 51 Diabetic Macular Edema 51 EcoNail 51 cathepsin K inhibitor 51 EOquin TM 51 CDP# 51 Signaling Pathways 51 Cellegesic 51 preclinical studies 51 Marketing Authorisation Application 51 Japanese Encephalitis vaccine 51 Zenvia ™ 51 serotonin norepinephrine reuptake inhibitor 51 Zoraxel 51 amrubicin 51 Orphan Drug designation 51 Cethromycin 51 IRX 2 51 LE DT 51 Cannabinoid 51 immune modulatory 51 Aerosurf 51 product BioThrax ® 51 investigational protease inhibitor 51 Neo Urinary Conduit 51 topical non steroidal 51 Sebivo 51 retapamulin 51 SIR Spheres 51 rALLy clinical trial 51 M1 muscarinic 51 Raltegravir 51 Fodosine 51 BRIM2 51 Immune Mediated 51 Genasense ® 51 DispersinB R 51 diagnostic molecular imaging 51 transdermal spray 51 HuMax CD4 51 Phase Ib II 51 forodesine hydrochloride 51 balsalazide tablet 51 Vilazodone 51 oxybutynin ATD TM 51 Removab 51 tezampanel 51 Teriparatide 50 icatibant 50 prodrug 50 phase IIa clinical 50 Neuroendocrine 50 Androxal TM 50 Kepivance 50 ADVEXIN 50 oral formulation 50 tanespimycin 50 eniluracil 50 Epitopes 50 transgenic mouse models 50 nonclinical studies 50 Tumor Angiogenesis 50 MPDs 50 GV# [001] 50 Sugammadex 50 Teysuno 50 Phase III clinical trials 50 opioid peptides 50 SomatoKine 50 phase Ib 50 Adhesion Barrier 50 Plenaxis TM 50 urothelial carcinoma 50 HEPLISAV TM 50 Phase Ib study 50 metastatic relapsed 50 Indaflex TM 50 intracellular signaling 50 Anturol TM 50 miconazole Lauriad R 50 Oncogene 50 Acute Radiation Syndrome ARS 50 randomized controlled Phase 50 Valtropin 50 Imprime PGG 50 Endeavor Drug Eluting 50 PS# [001] 50 Darusentan 50 Advagraf 50 registrational 50 Picoplatin 50 anti TNF alpha 50 Bezielle 50 RH1 50 Boceprevir 50 AZX# 50 metformin HCl 50 IND submission 50 Anticalin R 50 Rituxan rituximab 50 NexACT 50 Systemic Sclerosis 50 topical formulations 50 Onrigin 50 HuMax EGFr 50 post herpetic neuralgia PHN 50 Cethrin 50 Autoimmune Disease 50 TELCYTA 50 Biologic License Application BLA 50 LEVADEX TM 50 Allovectin 7 R 50 Roflumilast 50 bevacizumab Avastin 50 Homspera 50 Ixempra 50 INDs 50 dose escalation clinical 50 IND Investigational New 50 Oxiplex 50 TRANSDUR Sufentanil 50 T Pred 50 Dacogen injection 50 urethral bulking agent 50 application sNDA 50 ALVESCO R 50 Aztreonam 49 Fibrin Pad 49 NEUMUNE 49 adipiplon 49 QLT# 49 angiogenesis inhibitors 49 TNFR 49 riociguat 49 tremelimumab 49 Vimpat R 49 buccal insulin spray 49 Milnacipran 49 Anti TNF 49 Fibrillex TM 49 MK #B 49 Octreolin 49 Diamyd ® 49 Apoptosis 49 Ustekinumab 49 Maraviroc 49 Arzerra ofatumumab 49 Humira adalimumab 49 nanocarrier 49 Pharmacological 49 SPD# 49 Amplimexon 49 synthetic retinoid 49 microRNAs miRNAs 49 efficacy tolerability 49 insulin secreting 49 VEGF inhibitor 49 Atrasentan 49 Rifaximin 49 romidepsin 49 clinical trials 49 HCD# [002] 49 Ramelteon 49 Virulizin R 49 BYETTA ® 49 TAXUS TM 49 teduglutide 49 Phase IIa trials 49 relapsed multiple myeloma 49 Alferon N 49 LUVENIQ 49 intravitreal insert 49 intravenous formulations 49 temsirolimus 49 MYCAMINE 49 Mepact 49 oral ridaforolimus 49 Tamibarotene 49 Investigational Device 49 eltrombopag 49 REPEL CV 49 acyclovir Lauriad ® 49 atacicept 49 Phase IIb trials 49 cultured rat 49 oral methylnaltrexone 49 Dyloject TM 49 EndoTAG TM 49 Investigational 49 intercellular signaling 49 Biologics License Application BLA 49 LEVADEX ™ 49 Increlex R 49 Prednisporin TM 49 tolevamer 49 Ceftobiprole 49 Litx 48 Tasigna nilotinib 48 Phase Ib clinical 48 ligand binding 48 Tekturna HCT 48 DR Cysteamine 48 Abstral ® 48 ZYBRESTAT 48 refractory Hodgkin lymphoma 48 peginesatide 48 TRELSTAR R 48 Arranon 48 gallium nitrate injection 48 Mutational 48 IV acetaminophen 48 Certolizumab pegol 48 oral rivaroxaban 48 Cell Differentiation 48 relapsing multiple sclerosis 48 CERVARIX R 48 NP2 Enkephalin 48 hereditary deficiency 48 Ampligen R 48 NKTR 48 MAP kinase pathway 48 Biologics License Application 48 quinolone antibiotic 48 TREDAPTIVE 48 immunobiology 48 Fibroblast 48 Advexin 48 anti inflammatory NSAID 48 Pirfenidone 48 capecitabine Xeloda R 48 Tumor Microenvironment 48 Zelrix 48 Rilutek 48 cetrorelix pamoate 48 amyloid formation 48 ICA # 48 Phase 2a trial 48 NGX# 48 oral antifungal 48 Marketing Authorization Application 48 SEPET TM 48 integrase inhibitor 48 Phase IIIb clinical 48 Premarket Approval PMA 48 topical NSAID 48 Orapred ODT 48 Phase 1b trial 48 Liprostin 48 Exalgo TM 48 pomalidomide 48 Phase Ib 48 Glycopyrrolate 48 CRx 48 Orphan Drug Designation 48 Medicinal Chemistry Letters 48 TM Drug Eluting 48 Kv#.# 48 Belldegrun 48 investigational integrase inhibitor 48 Hematopoietic Stem Cells 48 boosted protease inhibitor 48 Serdaxin 48 AZILECT R 48 Phase 2b clinical trials 48 Topotecan 48 Gabapentin GR 48 systemic immunosuppressive drugs 48 HZT 48 JAK STAT 48 ADVANCE PD 48 Muscarinic 48 biologic therapy 48 OncoVEX 48 preclinical 48 Cimzia ® certolizumab pegol 48 Frova ® 48 Apixaban 48 proprietary biomaterials 48 ATryn ® 48 ancrod 48 Investigational Device Exemption IDE 48 Raptiva ® 47 lomitapide 47 urate lowering 47 Satraplatin 47 Reolysin 47 Ampligen r 47 Arcalyst 47 prGCD 47 Phase 2a clinical 47 Xyrem ® 47 elacytarabine 47 DORIBAX 47 Phase IIIb 47 Xcelerant Delivery System 47 Dabigatran etexilate 47 injectable formulations 47 OncoVEX GM CSF 47 AZILECT ® 47 recombinant human 47 urography 47 Bioorganic 47 omacetaxine 47 Neurogenic 47 oral iron chelator 47 Velcura 47 Cinacalcet 47 Emend 47 Skp2 47 mg kg BID 47 Marqibo 47 placebo controlled Phase 47 alvimopan 47 Novel Therapeutics 47 teriflunomide 47 dalbavancin 47 CCR5 inhibitor 47 capsule formulation 47 RDEA# 47 Glial 47 Toctino ® alitretinoin 47 topical antifungal 47 ONGLYZA ™ 47 MabCampath 47 Ozurdex 47 anti arrhythmic 47 ELIQUIS 47 Excellagen 47 PEG Interferon lambda 47 Phase 2b trial 47 clinical trial 47 Chrysalin 47 Investigational Device Exemption 47 angiogenic 47 Phase Ib IIa 47 StemEx 47 p#/CBP 47 Ipilimumab 47 diabetic macular edema DME 47 Molecular Basis 47 DP b# 47 Neurodegenerative Disease 47 UCB Cimzia 47 Hyphanox 47 PROMUS Element Stent 47 Testis 47 RG# [001] 47 orphan designation 47 blood clot dissolver 47 costimulatory 47 TEMODAL 47 Combidex 47 VEGF Trap 47 T DM1 47 Loramyc R 46 Phase 2b clinical 46 refractory APL 46 Cimzia TM 46 Junovan 46 Phase IIIb study 46 noninfectious uveitis 46 INT# [002] 46 Neuroinflammation 46 perifosine 46 Hexvix 46 Rivaroxaban 46 Clonicel 46 MD Ph.D 46 Cloretazine R VNP#M 46 DNAwithPap TM Test 46 opioid analgesic 46 Humanitarian Device Exemption 46 CLARITY study 46 MAXY G# 46 2A receptor 46 Kinase inhibitor 46 REG1 46 phase IIb 46 Cerashield 46 intravenous formulation 46 STEM CELLS 46 Retacrit 46 ophthalmic indications 46 EMBO Journal 46 #:#-# [003] 46 Alvesco R 46 prostacyclins 46 alogliptin 46 Rescula 46 IND enabling 46 morphogenesis 46 Arch Dis Child 46 FoxO1 46 phase IIa 46 FDA Investigational Device 46 Urocidin 46 OROS R Hydromorphone 46 Orazol 46 pharmacokinetic PK 46 Proteostasis Network 46 sNDA submission 46 USL# 46 ARIXTRA R 46 ryanodine receptor 46 apaziquone 46 Relistor 46 TRISENOX 46 PROSTVAC TM 46 neurogenic 45 Hycamtin 45 bilayered 45 Neuromodulation System 45 etravirine 45 dirucotide 45 CardioFit 45 Viprinex 45 casopitant 45 developing ViaCyte SM 45 PRISTIQ 45 Pharmacologic 45 CE Marked